Monte Rosa Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $143,311,000.
Profit Margin
| 2019 | 0 | -8.01M | |
|---|---|---|---|
| 2020 | 0 | -36.06M | |
| 2021 | 0 | -71.94M | |
| 2022 | 0 | -104.61M | |
| 2023 | 0 | -135.35M |
GLUE Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 6.22M | 8.55M | 2.13M | 537K | 72K |
Gross profit | -6.22M | -8.55M | -2.13M | -537K | -72K |
Operating exp. | |||||
Research and development | 111.27M | 85.06M | 57.15M | 24.00M | 7.35M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 143.31M | 112.38M | 72.88M | 28.01M | 7.99M |
Operating income | -143.31M | -112.38M | -72.88M | -28.01M | -7.99M |
Other income (expenses), net | 8.29M | 3.88M | -1.07M | -7.86M | 254K |
Income before tax | -135.01M | -108.50M | -73.95M | -35.87M | -7.74M |
Income tax expense | 338K | -3.88M | -2.01M | 189K | 277K |
Net income | -135.35M | -104.61M | -71.94M | -36.06M | -8.01M |
Earnings per share | |||||
Basic EPS | -2.63 | -2.22 | -1.55 | -0.82 | -0.18 |
Diluted EPS | -2.63 | -2.22 | -1.55 | -0.82 | -0.18 |
| Data source | Data source | Data source |